LXS Stock Overview
Operates as a specialty chemicals company that engages in the development, manufacture, and marketing of chemical intermediates, additives, specialty chemicals, and consumer protection products worldwide. More details
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 3/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
LANXESS Aktiengesellschaft Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €23.31 |
| 52 Week High | €29.80 |
| 52 Week Low | €21.00 |
| Beta | 1.61 |
| 11 Month Change | -18.75% |
| 3 Month Change | -6.39% |
| 1 Year Change | 3.23% |
| 33 Year Change | -57.59% |
| 5 Year Change | -61.67% |
| Change since IPO | 57.08% |
Recent News & Updates
Does LANXESS (ETR:LXS) Have A Healthy Balance Sheet?
Oct 30
Why We're Not Concerned About LANXESS Aktiengesellschaft's (ETR:LXS) Share Price
Sep 07Recent updates
Does LANXESS (ETR:LXS) Have A Healthy Balance Sheet?
Oct 30Why We're Not Concerned About LANXESS Aktiengesellschaft's (ETR:LXS) Share Price
Sep 07Is LANXESS (ETR:LXS) Using Debt Sensibly?
Jul 23Is It Too Late To Consider Buying LANXESS Aktiengesellschaft (ETR:LXS)?
May 27Why Investors Shouldn't Be Surprised By LANXESS Aktiengesellschaft's (ETR:LXS) P/S
May 08Is There An Opportunity With LANXESS Aktiengesellschaft's (ETR:LXS) 42% Undervaluation?
Apr 20Is LANXESS (ETR:LXS) Weighed On By Its Debt Load?
Mar 22What You Can Learn From LANXESS Aktiengesellschaft's (ETR:LXS) P/S
Jan 27Is LANXESS (ETR:LXS) Using Too Much Debt?
Dec 05A Look At The Fair Value Of LANXESS Aktiengesellschaft (ETR:LXS)
Nov 01When Should You Buy LANXESS Aktiengesellschaft (ETR:LXS)?
Sep 11These 4 Measures Indicate That LANXESS (ETR:LXS) Is Using Debt In A Risky Way
Aug 20Calculating The Fair Value Of LANXESS Aktiengesellschaft (ETR:LXS)
Aug 01When Should You Buy LANXESS Aktiengesellschaft (ETR:LXS)?
Jun 08Is LANXESS (ETR:LXS) A Risky Investment?
May 16LANXESS Aktiengesellschaft's (ETR:LXS) Intrinsic Value Is Potentially 28% Above Its Share Price
Apr 26Is Now The Time To Look At Buying LANXESS Aktiengesellschaft (ETR:LXS)?
Feb 17These 4 Measures Indicate That LANXESS (ETR:LXS) Is Using Debt Extensively
Jan 30Is There An Opportunity With LANXESS Aktiengesellschaft's (ETR:LXS) 25% Undervaluation?
Jan 12Is There Now An Opportunity In LANXESS Aktiengesellschaft (ETR:LXS)?
Nov 03We Think LANXESS (ETR:LXS) Is Taking Some Risk With Its Debt
Oct 11Is It Too Late To Consider Buying LANXESS Aktiengesellschaft (ETR:LXS)?
Aug 03LANXESS (ETR:LXS) Has A Somewhat Strained Balance Sheet
Jul 11LANXESS' (ETR:LXS) Dividend Will Be Increased To €1.05
May 09LANXESS (ETR:LXS) Will Pay A Larger Dividend Than Last Year At €1.05
Apr 21LANXESS' (ETR:LXS) Shareholders Will Receive A Bigger Dividend Than Last Year
Apr 04LANXESS (ETR:LXS) Is Increasing Its Dividend To €1.05
Mar 13At €53.00, Is It Time To Put LANXESS Aktiengesellschaft (ETR:LXS) On Your Watch List?
Feb 07We Think LANXESS (ETR:LXS) Can Stay On Top Of Its Debt
Jan 17At €59.04, Is It Time To Put LANXESS Aktiengesellschaft (ETR:LXS) On Your Watch List?
Oct 26Shareholder Returns
| LXS | DE Chemicals | DE Market | |
|---|---|---|---|
| 7D | 3.2% | -0.6% | -0.2% |
| 1Y | 3.2% | -0.6% | 7.8% |
Return vs Industry: LXS exceeded the German Chemicals industry which returned -0.6% over the past year.
Return vs Market: LXS underperformed the German Market which returned 7.8% over the past year.
Price Volatility
| LXS volatility | |
|---|---|
| LXS Average Weekly Movement | 5.0% |
| Chemicals Industry Average Movement | 4.3% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 11.1% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: LXS has not had significant price volatility in the past 3 months compared to the German market.
Volatility Over Time: LXS's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1863 | 12,849 | Frederique van Baarle | lanxess.com |
LANXESS Aktiengesellschaft, together with its subsidiaries, operates as a specialty chemicals company that engages in the development, manufacture, and marketing of chemical intermediates, additives, specialty chemicals, and consumer protection products worldwide. It operates through three segments: Consumer Protection, Specialty Additives, and Advanced Intermediates. The Consumer Protection segment provides material protection products; disinfectant, hygiene, and preservative solutions; flavors and fragrances; liquid purification technologies for the treatment of water and other liquids; and precursors and intermediates for the agrochemicals, pharmaceuticals, and specialty chemicals industries.
LANXESS Aktiengesellschaft Fundamentals Summary
| LXS fundamental statistics | |
|---|---|
| Market cap | €2.01b |
| Earnings (TTM) | -€690.00m |
| Revenue (TTM) | €6.32b |
0.3x
P/S Ratio-2.9x
P/E RatioIs LXS overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| LXS income statement (TTM) | |
|---|---|
| Revenue | €6.32b |
| Cost of Revenue | €5.09b |
| Gross Profit | €1.23b |
| Other Expenses | €1.92b |
| Earnings | -€690.00m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -7.99 |
| Gross Margin | 19.39% |
| Net Profit Margin | -10.92% |
| Debt/Equity Ratio | 68.8% |
How did LXS perform over the long term?
See historical performance and comparison